|
[1]
|
Elagizi, A., Kachur, S., Carbone, S., Lavie, C. and Blair, S.N. (2020) A Review of Obesity, Physical Activity, and Car-diovascular Disease. Current Obesity Reports, 9, 571-581. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Rohm, T.V., Meier, D.T., Olefsky, J.M. and Donath, M.Y. (2022) Inflammation in Obesity, Diabetes, and Related Disorders. Immunity, 55, 31-55. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Chrysant, S.G. (2019) Pathophysiology and Treatment of Obesity-Related Hypertension. The Journal of Clinical Hypertension, 21, 555-559. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Aboonabi, A., Meyer, R.R. and Singh, I. (2019) The Association between Metabolic Syndrome Components and the Development of Atherosclerosis. Journal of Human Hypertension, 33, 844-855. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Geeraerts, X., Bolli, E., Fendt, S.M. and Van Ginderachter, J.A. (2017) Macrophage Metabolism as Therapeutic Target for Cancer, Atherosclerosis, and Obesity. Frontiers in Immunol-ogy, 8, Article 289. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Nagarajan, S.R., Cross, E., Sanna, F. and Hodson, L. (2022) Dysregulation of Hepatic Metabolism with Obesity: Factors Influencing Glucose and Lipid Metabolism. Proceedings of the Nutrition Society, 81, 1-11. [Google Scholar] [CrossRef]
|
|
[7]
|
Goncalves, I., Sun, J., Tengryd, C., et al. (2021) Plaque Vul-nerability Index Predicts Cardiovascular Events: A Histological Study of an Endarterectomy Cohort. Journal of the American Heart Association, 10, e021038. [Google Scholar] [CrossRef]
|
|
[8]
|
中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2021概要[J]. 心脑血管病防治, 2022, 22(4): 20-36+40.
|
|
[9]
|
Rehberger Likozar, A., Zavrtanik, M. and Šebeštjen, M. (2020) Lipoprotein(a) in Atherosclerosis: From Pathophysiology to Clinical Relevance and Treatment Options. An-nals of Medicine, 52, 162-177. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
中国营养学会肥胖防控分会, 中国营养学会临床营养分会, 中华预防医学会行为健康分会, 中华预防医学会体育运动与健康分会. 中国居民肥胖防治专家共识[J]. 中国预防医学杂志, 2022, 23(5): 321-339.
|
|
[11]
|
魏亚琳. 颈动脉硬化影响因素的决策树模型研究[D]: [硕士学位论文]. 青岛: 青岛大学, 2021.
|
|
[12]
|
Maranhão, R.C., Carvalho, P.O., Strunz, C.C. and Pileggi, F. (2014) Lipoprotein(a): Structure, Pathophysiology and Clinical Implications. Arquivos Brasileiros de Cardiologia, 103, 76-84. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Rawther, T. and Tabet, F. (2019) Biology, Pathophysiology and Current Therapies That Affect Lipoprotein (a) Levels. Journal of Molecular and Cellular Cardiology, 131, 1-11. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Allen, S., Khan, S., Tam, S., Koschinsky, M., Taylor, P. and Yacoub, M. (1998) Expression of Adhesion Molecules by Lp(a): A Potential Novel Mechanism for Its Atherogenicity. The FASEB Journal, 12, 1765-1776. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Argraves, K.M., Kozarsky, K.F., Fallon, J.T., Harpel, P.C. and Strickland, D.K. (1997) The Atherogenic Lipoprotein Lp(a) Is Internalized and Degraded in a Process Mediated by the VLDL Receptor. Journal of Clinical Investigation, 100, 2170-2181. [Google Scholar] [CrossRef]
|
|
[16]
|
Wu, H.D., et al. (2004) High Lipoprotein(a) Levels and Small Apolipoprotein(a) Sizes Are Associated with Endothelial Dys-function in a Multiethnic Cohort. Journal of the American College of Cardiology, 43, 1828-1833. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Scipione, C.A., et al. (2015) Mechanistic Insights into Lp(a)-Induced IL-8 Expression: A Role for Oxidized Phospholipid Modification of Apo(a). Journal of Lipid Research, 56, 2273-2285. [Google Scholar] [CrossRef]
|
|
[18]
|
Dangas, G., et al. (1998) Lipoprotein(a) and Inflamma-tion in Human Coronary Atheroma: Association with the Severity of Clinical Presentation. Journal of the American Col-lege of Cardiology, 32, 2035-2042. [Google Scholar] [CrossRef]
|
|
[19]
|
徐东进. 同型半胱氨酸、脂蛋白a及载脂蛋白AI/载脂蛋白B水平与缺血性脑卒中患者凝血指标相关性的探讨[J]. 吉林医学, 2023, 44(1): 68-71.
|
|
[20]
|
任云霞, 王斌, 吕淑萍, 程晋芳, 高宇平. 冠心病病人脂蛋白a与冠状动脉病变的相关性[J]. 中西医结合心脑血管病杂志, 2021, 19(22): 3963-3965+3971.
|